https://www.selleckchem.com/products/Nolvadex.html
833-8.898, P=.0118), and paraspinal disease (OR 2.874, 95% CI 1.118-7.393, P=.0288) were prognostic for ≤3 mo survival. The 3- and 5-yr rates of VCF were 10.4% and 14.4%, respectively, and 3- and 5-yr rates of plexopathy were 2.2% and 5.1%, respectively. A single duodenal perforation was observed, and there was no radiation myelopathy events. Shorter survival after spine SBRT was seen in patients with less radiosensitive histologies (ie, not breast or prostate), ECOG ≥2, and polymetastatic disease. Pain and paraspinal disease were also
Gefällt mir
Kommentar
Teilen
